Related by context. Frequent words. (Click for all words.) 66 INTEGRILIN 62 lipid lowering agents 62 dyslipidaemia 62 atherothrombosis 62 rufinamide 62 NYHA Class II 61 secondary hyperparathyroidism 61 venous thromboembolic events 61 Fibrillex TM 61 NATRECOR R 61 R sorafenib tablets 61 refractory angina 61 cerebrovascular events 61 inflammatory autoimmune diseases 60 ONTAK 60 Increlex ® 60 chemotherapy induced neutropenia 60 rFVIIa 60 acute coronary syndromes 60 thromboembolic 60 PROVIGIL 60 acute coronary syndromes ACS 60 TRISENOX 59 THALOMID 59 Soliris TM eculizumab 59 oxcarbazepine 59 thrombolytics 59 revascularization procedures 59 intracoronary 59 arterial thrombosis 59 olmesartan 59 TEAEs 59 NUEDEXTA 59 sunitinib malate 59 PEG INTRON 58 extracranial 58 Actimmune R 58 EFAPROXYN 58 Tekamlo 58 lipid parameters 58 angina pectoris 58 ARCOXIA 58 acute myocardial infarction AMI 58 ischemic cardiomyopathy 58 coronary intervention 58 forodesine 58 exocrine pancreatic insufficiency 58 patients undergoing percutaneous 58 neutropenia thrombocytopenia 58 cardio metabolic 58 efalizumab 58 lipid lowering drugs 58 Panzem R 58 poor metabolizers 58 antiepileptic 58 Amrubicin 58 MERLIN TIMI 58 cardiac dysfunction 58 post herpetic neuralgia PHN 58 Candesartan 58 irbesartan 58 PRADAXA 58 Secondary endpoints include 58 ezetimibe simvastatin 58 Entereg R 57 chronic angina 57 teriflunomide 57 ovarian breast 57 Nexavar ® 57 omecamtiv mecarbil 57 alvimopan 57 acute GVHD 57 QTc prolongation 57 myocardial ischemia 57 osteoarthritis rheumatoid arthritis 57 Natalizumab 57 efficacy tolerability 57 carbidopa levodopa 57 Eloxatin ® 57 renal anemia 57 pancreatic insufficiency 57 Ethyol 57 Ischemic stroke 57 AVANDIA 57 tumor lysis syndrome 57 renal dysfunction 57 prophylactic therapy 57 TH# [003] 57 calcineurin inhibitors 57 TAXUS Stent 57 extrapyramidal symptoms 57 neurovascular diseases 57 Losartan 57 hypercholesterolemia 57 frovatriptan 57 antihypertensive agents 57 heparin induced thrombocytopenia 57 liposomal formulation 57 Gefitinib 57 multiple sclerosis rheumatoid arthritis 57 PROMACTA